| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 566,8 k € | -0.9% | 572,2 k € | +25.9% | 454,5 k € | -10.6% | 508,4 k € | +2.5% | 496,2 k € | +0.4% | 494,2 k € | -5.4% | 522,5 k € | +40.0% | 373,3 k € | -10.8% | 418,4 k € | +1.8% | 411,0 k € | -5.4% | 434,4 k € | +86.4% | 233,0 k € | -41.4% | 397,8 k € | +0.5% | 395,9 k € | +27.6% | 310,2 k € | -14.9% | 364,3 k € | -4.4% | 381,1 k € | -0.4% | 382,5 k € | +8.7% | 351,9 k € | +43.6% | 245,1 k € | |
| EBITDA | 561,5 k € | -1.1% | 567,6 k € | +26.2% | 449,9 k € | -10.4% | 502,2 k € | +1.7% | 493,8 k € | +1.2% | 487,9 k € | -5.2% | 514,6 k € | +40.7% | 365,7 k € | -11.9% | 415,3 k € | +1.9% | 407,7 k € | -5.1% | 429,7 k € | +90.3% | 225,8 k € | -42.3% | 391,4 k € | -0.2% | 392,1 k € | +28.3% | 305,5 k € | -15.4% | 361,2 k € | -3.7% | 375,0 k € | -1.1% | 379,4 k € | +8.9% | 348,3 k € | +44.1% | 241,7 k € | |
| Operating profit | 499,9 k € | -0.7% | 503,5 k € | +33.0% | 378,6 k € | -12.4% | 432,0 k € | +4.1% | 415,0 k € | -2.4% | 425,3 k € | -6.8% | 456,4 k € | +42.9% | 319,4 k € | -11.3% | 360,1 k € | +2.5% | 351,3 k € | +0.2% | 350,5 k € | +120.2% | 159,2 k € | -50.8% | 323,5 k € | -0.0% | 323,6 k € | +42.2% | 227,5 k € | -19.0% | 280,9 k € | -7.3% | 303,0 k € | +29.8% | 233,5 k € | +15.7% | 201,9 k € | +99.6% | 101,2 k € | |
| Profit/loss | 350,1 k € | -1.8% | 356,6 k € | +35.3% | 263,5 k € | -12.1% | 299,8 k € | +4.8% | 286,1 k € | +12.0% | 255,4 k € | -15.3% | 301,7 k € | +42.9% | 211,1 k € | -4.3% | 220,5 k € | +5.2% | 209,7 k € | -1.5% | 212,9 k € | +114.9% | 99,0 k € | -52.9% | 210,5 k € | +7.5% | 195,7 k € | +50.4% | 130,1 k € | -24.9% | 173,3 k € | -13.6% | 200,4 k € | +45.1% | 138,2 k € | +21.4% | 113,8 k € | +149.6% | 45,6 k € | |
| Equity | 1,9 M € | +2.6% | 1,9 M € | +8.5% | 1,7 M € | +2.6% | 1,7 M € | +5.8% | 1,6 M € | +5.7% | 1,5 M € | +20.7% | 1,2 M € | +32.4% | 931,7 k € | +29.3% | 720,6 k € | -9.6% | 797,1 k € | +35.7% | 587,3 k € | +25.7% | 467,4 k € | +26.9% | 368,4 k € | -5.8% | 390,8 k € | +100.3% | 195,1 k € | -53.0% | 415,0 k € | +0.8% | 411,7 k € | +0.1% | 411,3 k € | -0.2% | 412,1 k € | +8.9% | 378,3 k € | |
| Total assets | 1,9 M € | +1.4% | 1,9 M € | +10.7% | 1,7 M € | +0.2% | 1,7 M € | +7.5% | 1,6 M € | -5.2% | 1,7 M € | +30.8% | 1,3 M € | +36.3% | 940,3 k € | -7.8% | 1,0 M € | +23.8% | 823,9 k € | +17.3% | 702,2 k € | +22.7% | 572,1 k € | -17.3% | 692,0 k € | +31.3% | 527,2 k € | -11.5% | 595,8 k € | -30.5% | 856,8 k € | -5.4% | 906,1 k € | +4.4% | 867,9 k € | +4.2% | 832,9 k € | +2.5% | 812,5 k € | |
| Cash | 493,2 k € | -48.0% | 948,0 k € | +107.6% | 456,7 k € | -38.7% | 745,1 k € | -6.9% | 800,0 k € | +0.3% | 797,4 k € | +34.1% | 594,8 k € | +45.3% | 409,4 k € | -11.5% | 462,6 k € | +75.1% | 264,2 k € | -25.9% | 356,3 k € | +119.3% | 162,4 k € | -55.1% | 361,7 k € | +157.2% | 140,6 k € | -8.6% | 153,9 k € | -58.1% | 367,3 k € | -1.0% | 370,9 k € | +710.2% | 45,8 k € | -10.8% | 51,3 k € | -27.9% | 71,2 k € | |
| Debts | 20,4 k € | -52.7% | 43,2 k € | +844.1% | 4,6 k € | -89.5% | 43,7 k € | +164.1% | 16,5 k € | -91.2% | 187,8 k € | +287.8% | 48,4 k € | +464.9% | 8,6 k € | -97.1% | 299,5 k € | +1016.3% | 26,8 k € | -76.6% | 114,9 k € | +9.8% | 104,6 k € | -67.7% | 323,6 k € | +137.4% | 136,3 k € | -66.0% | 400,7 k € | -9.3% | 441,9 k € | -10.6% | 494,4 k € | +8.3% | 456,6 k € | +8.5% | 420,8 k € | -3.1% | 434,2 k € | |
Private limited company · Ieper · incorporated on 06/06/1996
Private limited company profitable and well capitalised. Cash position declining (-48.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
VERBANCK-MALYSSE DOKTERS is a Private limited company incorporated in 1996. Its main activity is: Specialist medical practice activities. Its registered office is in Ieper.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette